As of Aug 27
| +0.06 / +2.22%|
The 5 analysts offering 12-month price forecasts for Orexigen Therapeutics Inc have a median target of 9.00, with a high estimate of 21.00 and a low estimate of 8.00. The median estimate represents a +226.09% increase from the last price of 2.76.
The current consensus among 6 polled investment analysts is to Buy stock in Orexigen Therapeutics Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.